Back to Search
Start Over
λ Recombineering Used to Engineer the Genome of Phage T7
- Source :
- Antibiotics, Antibiotics, Vol 9, Iss 805, p 805 (2020), Volume 9, Issue 11
- Publication Year :
- 2020
-
Abstract
- Bacteriophage T7 and T7-like bacteriophages are valuable genetic models for lytic phage biology that have heretofore been intractable with in vivo genetic engineering methods. This manuscript describes that the presence of &lambda<br />Red recombination proteins makes in vivo recombineering of T7 possible, so that single base changes and whole gene replacements on the T7 genome can be made. Red recombination functions also increase the efficiency of T7 genome DNA transfection of cells by ~100-fold. Likewise, Red function enables two other T7-like bacteriophages that do not normally propagate in E. coli to be recovered following genome transfection. These results constitute major technical advances in the speed and efficiency of bacteriophage T7 engineering and will aid in the rapid development of new phage variants for a variety of applications.
- Subjects :
- 0301 basic medicine
Microbiology (medical)
phage therapy
Phage therapy
medicine.medical_treatment
bacteriophage genetics
Computational biology
Biochemistry
Microbiology
Genome
Recombineering
Article
Bacteriophage
03 medical and health sciences
0302 clinical medicine
bacteriophage engineering
Genetic model
medicine
Pharmacology (medical)
General Pharmacology, Toxicology and Pharmaceutics
Bacteriophage Genetics
Gene
biology
lcsh:RM1-950
biology.organism_classification
recombineering
030104 developmental biology
Infectious Diseases
lcsh:Therapeutics. Pharmacology
Lytic cycle
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 20796382
- Volume :
- 9
- Issue :
- 11
- Database :
- OpenAIRE
- Journal :
- Antibiotics (Basel, Switzerland)
- Accession number :
- edsair.doi.dedup.....84f311f328f931623c13206b95da8b17